Sarepta Therapeutics (SRPT) Surges After Hours

September 13, 2016 5:25 PM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Sarepta Therapeutics (NASDAQ: SRPT) gaining on chatter Ron Farkas is no longer at the FDA. Shares are up 10%.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

FDA, Momentum Movers, Rumors, Trader Talk

Add Your Comment